Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Li Di. (2023) Recent advances in measurement of metabolic clearance, metabolite profile and reaction phenotyping of low clearance compounds. Expert Opinion on Drug Discovery 18:11, pages 1209-1219.
Read now
Read now
Ragini Vuppugalla, Ramola Sane, Michael Wichroski, Ashvini Kumar Gavai, Sarandeep Boyanapalli & Zheng Yang. (2021) Prospective prediction of plasma pharmacokinetics of a novel immune-modulating agent in cancer patients after intra-tumoral administration: translation from non-clinical species to humans. Xenobiotica 51:11, pages 1255-1263.
Read now
Read now
Eva Germovsek, Ming Cheng & Craig Giragossian. (2021) Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settings. mAbs 13:1.
Read now
Read now
Ali Kermanizadeh, Leagh G Powell, Vicki Stone & Peter Møller. (2018) Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape. International Journal of Nanomedicine 13, pages 7575-7605.
Read now
Read now
Seigo Sanoh, Yoichi Naritomi, Mami Fujimoto, Koya Sato, Akio Kawamura, Aya Horiguchi, Kazumi Sugihara, Yaichiro Kotake, Hiroki Ohshita, Chise Tateno, Toru Horie, Shigeyuki Kitamura & Shigeru Ohta. (2015) Predictability of plasma concentration–time curves in humans using single-species allometric scaling of chimeric mice with humanized liver. Xenobiotica 45:7, pages 605-614.
Read now
Read now
Qingbiao Huang & Jim E Riviere. (2014) The application of allometric scaling principles to predict pharmacokinetic parameters across species. Expert Opinion on Drug Metabolism & Toxicology 10:9, pages 1241-1253.
Read now
Read now
Elliot Offman & Andrea N. Edginton. (2013) Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development. Xenobiotica 43:6, pages 561-569.
Read now
Read now
Articles from other publishers (51)
Sebastian Sten, Tim Cardilin, Madeleine Antonsson & Peter Gennemark. (2023) Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs). Clinical Pharmacokinetics 62:12, pages 1661-1672.
Crossref
Crossref
Jingchen Zhai, Viet Hoang Man, Beihong Ji, Lianjin Cai & Junmei Wang. (2023) Comparison and summary of in silico prediction tools for CYP450-mediated drug metabolism. Drug Discovery Today 28:10, pages 103728.
Crossref
Crossref
Raju Prasad Sharma, Elsje J. Burgers & Joost B. Beltman. (2023) Development of a Physiologically Based Pharmacokinetic Model for Nitrofurantoin in Rabbits, Rats, and Humans. Pharmaceutics 15:9, pages 2199.
Crossref
Crossref
Gregory Jones, Lingxue Zeng & Jonghan Kim. (2023) Application of Allometric Scaling to Nanochelator Pharmacokinetics. ACS Omega 8:30, pages 27256-27263.
Crossref
Crossref
Bradford Gutting, Joseph Gillard & Gabriel Intano. (2023) Physiologically-based toxicokinetic model of botulinum neurotoxin biodistribution in mice and rats. Computational Toxicology 27, pages 100278.
Crossref
Crossref
Michael J. White, Letitia Cheatham, Shenghua Wen, Graeme Scarfe, Justin Cidado, Corinne Reimer, Niresh Hariparsad, Rhys D. O. Jones, Lisa Drew, Dermot F. McGinnity & Christina Vasalou. (2023) A PKPD Case Study: Achieving Clinically Relevant Exposures of AZD5991 in Oncology Mouse Models. The AAPS Journal 25:4.
Crossref
Crossref
Yeshwant Singh, Ravi AkkiReddy, Deepti Sahu, Giridhar Bilagi, Theertha Thykandy, Prajakta Hingole, Deveshkumar Rana, Roopa Naraganti, Sudhir Kumar Tiwari & Pratima Srivastava. (2023) Intersex and interspecies pharmacokinetics of metoprolol after oral and intravenous dose administration in rats and mice. International Journal of Pharmacokinetics 7:1.
Crossref
Crossref
Xiaoqing Fan, Wojciech Krzyzanski, Dongyang Liu, Raymond S. M. Wong & Xiaoyu Yan. (2023) Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia. Pharmaceutics 15:2, pages 344.
Crossref
Crossref
Robin Maximilian Awad & Karine Breckpot. 2023.
Muhammad Sajid Hamid Akash, Kanwal Rehman, Kanwal Irshad & Shuqing Chen. 2023. Pharmaceutical Biotechnology in Drug Development. Pharmaceutical Biotechnology in Drug Development
35
56
.
Paige N. Zambrana, Dana C. Hammell & Audra L. Stinchcomb. (2022) Advanced harmonization techniques result in accurate establishment of in vitro–in vivo correlations for oxybenzone from four complex dermal formulations with reapplication. Drug Delivery and Translational Research 13:1, pages 275-291.
Crossref
Crossref
Patrick McMullen, Liang Fang, Qi Qiao, Qing Shao & Shaoyi Jiang. (2022) Impacts of a Zwitterionic Peptide on its Fusion Protein. Bioconjugate Chemistry 33:8, pages 1485-1493.
Crossref
Crossref
Sandra Wymann, Marcel Mischnik, David Leong, Subhajit Ghosh, Xiahui Tan, Helen Cao, Benjamin Kuehnemuth, Glenn A. Powers, Partho Halder, Mitchell J. de Souza, Hannah S. James, Vesna Tomasetig, Holger Lind, Paolo Rossato, Catherine M. Owczarek, Saw Yen Ow, Steven K. Dower, Adriana Baz Morelli, Tony Rowe & Matthew P. Hardy. (2022)
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity
in vivo
. Biochemical Journal 479:9, pages 1007-1030.
Crossref
Crossref
A. Young J. Park, Dat Q. Tran, Justin B. Schaal, Mengxi Wang, Michael E. Selsted & Paul M. Beringer. (2022) Preclinical Pharmacokinetics and Safety of Intravenous RTD-1. Antimicrobial Agents and Chemotherapy 66:3.
Crossref
Crossref
Kit-Kay Mak, Ola Epemolu & Mallikarjuna Rao Pichika. (2022) The role of DMPK science in improving pharmaceutical research and development efficiency. Drug Discovery Today 27:3, pages 705-729.
Crossref
Crossref
Yekbun Adiguzel. (2021) Information‐theoretic approach in allometric scaling relations of DNA and proteins. Chemical Biology & Drug Design 99:2, pages 331-343.
Crossref
Crossref
Anne M. Talkington, Timothy Wessler, Samuel K. Lai, Yanguang Cao & M. Gregory Forest. (2021) Experimental Data and PBPK Modeling Quantify Antibody Interference in PEGylated Drug Carrier Delivery. Bulletin of Mathematical Biology 83:12.
Crossref
Crossref
Frederike Nordmeier, Iryna Sihinevich, Adrian A. Doerr, Nadja Walle, Matthias W. Laschke, Thorsten Lehr, Michael D. Menger, Peter H. Schmidt, Markus R. Meyer & Nadine Schaefer. (2021) Toxicokinetics of U-47700, tramadol, and their main metabolites in pigs following intravenous administration: is a multiple species allometric scaling approach useful for the extrapolation of toxicokinetic parameters to humans?. Archives of Toxicology 95:12, pages 3681-3693.
Crossref
Crossref
Duhyeong Hwang, Natasha Vinod, Sarah L. Skoczen, Jacob D. Ramsey, Kelsie S. Snapp, Stephanie A. Montgomery, Mengzhe Wang, Chaemin Lim, Jonathan E. Frank, Marina Sokolsky-Papkov, Zibo Li, Hong Yuan, Stephan T. Stern & Alexander V. Kabanov. (2021) Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay. Biomaterials 278, pages 121140.
Crossref
Crossref
He WeiAgata WiśniowskaJingxuan FanPeter HarveyYuanyuan LiVictoria WuEric C. HansenJuanye ZhangMichael G. KaulAbigail M FreyGerhard AdamAnatoly I. Frenkel, Moungi G. BawendiAlan Jasanoff. (2021) Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents. Proceedings of the National Academy of Sciences 118:42.
Crossref
Crossref
Disha Panchal, Jeena Kataria, Kamiya Patel, Kaytlyn Crowe, Varun Pai, Abdul‐Rahman Azizogli, Neil Kadian, Sreya Sanyal, Abhishek Roy, Joseph Dodd‐o, Amanda M. Acevedo‐Jake & Vivek A. Kumar. (2021) Peptide‐Based Inhibitors for SARS‐CoV‐2 and SARS‐CoV. Advanced Therapeutics 4:10.
Crossref
Crossref
Charvi NanavatiGina McMullenRosie YuRichard S. GearyScott P. HenryYanfeng Wang. (2021) Interspecies Scaling of Human Clearance and Plasma Trough Exposure for Antisense Oligonucleotides: A Retrospective Analysis of GalNAc3-Conjugated and Unconjugated-Antisense Oligonucleotides. Nucleic Acid Therapeutics 31:4, pages 298-308.
Crossref
Crossref
Nadia O. Bamfo, Chelsea Hosey-Cojocari, Leslie Z. Benet & Connie M. Remsberg. (2021) Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans. Pharmaceutical Research 38:7, pages 1139-1156.
Crossref
Crossref
Dawei Song & William J Jusko. (2021) Across‐species meta‐analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches. Biopharmaceutics & Drug Disposition 42:5, pages 191-203.
Crossref
Crossref
Tomás Sou, Jon Hansen, Edgars Liepinsh, Maria Backlund, Onur Ercan, Solveiga Grinberga, Sha Cao, Paraskevi Giachou, Anna Petersson, Magdalena Tomczak, Malgorzata Urbas, Dorota Zabicka, Carina Vingsbo Lundberg, Diarmaid Hughes, Sven N. Hobbie & Lena E. Friberg. (2020) Model‐Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin. Clinical Pharmacology & Therapeutics 109:4, pages 1063-1073.
Crossref
Crossref
Ali Kermanizadeh, Nicklas Raun Jacobsen, Fiona Murphy, Leagh Powell, Lee Parry, Haiyuan Zhang & Peter Møller. (2020) A Review of the Current State of Nanomedicines for Targeting and Treatment of Cancers: Achievements and Future Challenges. Advanced Therapeutics 4:2.
Crossref
Crossref
Jacqueline P. ErnestNatasha StrydomQianwen WangNan ZhangEric Nuermberger, Véronique Dartois & Rada M. Savic. (2021) Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis. Annual Review of Pharmacology and Toxicology 61:1, pages 495-516.
Crossref
Crossref
Paul R. Stabach, Kristin Zimmerman, Aaron Adame, Dillon Kavanagh, Christopher T. Saeui, Christian Agatemor, Shawn Gray, Wenxiang Cao, Enrique M. De La Cruz, Kevin J. Yarema & Demetrios T. Braddock. (2020) Improving the Pharmacodynamics and In Vivo Activity of ENPP1‐Fc Through Protein and Glycosylation Engineering. Clinical and Translational Science 14:1, pages 362-372.
Crossref
Crossref
Sarah Kim, Charles A. Scanga, Carolina de Miranda Silva, Matthew Zimmerman, Chelsea Causgrove, Brianne Stein, Véronique Dartois, Charles A. Peloquin, Emily Graham, Arnold Louie, JoAnne L. Flynn, Stephan Schmidt & George L. Drusano. (2020) Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates. European Journal of Pharmaceutical Sciences 151, pages 105421.
Crossref
Crossref
Huixi Zou, Parikshit Banerjee, Sharon Shui Yee Leung & Xiaoyu Yan. (2020) Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges. Frontiers in Pharmacology 11.
Crossref
Crossref
Clemens Günther, Kristin Kowal, Timm Schmidt, Alen Jambrecina, Frank Toner & Rüdiger Nave. (2019) Comparison of In Vitro and In Vivo Percutaneous Absorption Across Human Skin Using BAY1003803 Formulated as Ointment and Cream. Clinical Pharmacology in Drug Development 9:5, pages 582-592.
Crossref
Crossref
John O’Donnell, Angela Tanudra, April Chen, Daniel Hines, Ruben Tommasi & John Mueller. (2020) Pharmacokinetic/Pharmacodynamic Determination and Preclinical Pharmacokinetics of the β-Lactamase Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282. ACS Infectious Diseases 6:6, pages 1378-1388.
Crossref
Crossref
Laura Jablonka, Mukul Ashtikar, Ge Fiona Gao, Manuela Thurn, Harshvardhan Modh, Jiong-Wei Wang, Annegret Preuß, Dietrich Scheglmann, Volker Albrecht, Beate Röder & Matthias G. Wacker. (2020) Predicting human pharmacokinetics of liposomal temoporfin using a hybrid in silico model. European Journal of Pharmaceutics and Biopharmaceutics 149, pages 121-134.
Crossref
Crossref
Katja Jansen, Carla Pou Casellas, Lucianne Groenink, Kimberley E. Wever & Rosalinde Masereeuw. (2020) Humans are animals, but are animals human enough? A systematic review and meta-analysis on interspecies differences in renal drug clearance. Drug Discovery Today 25:4, pages 706-717.
Crossref
Crossref
Suein Choi, Seunghoon Han, Sangil Jeon & Dong-Seok Yim. (2019) Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP). Pharmaceutics 11:7, pages 336.
Crossref
Crossref
Christine M. Bowman & Leslie Z. Benet. (2019) In Vitro-In Vivo Extrapolation and Hepatic Clearance-Dependent Underprediction. Journal of Pharmaceutical Sciences 108:7, pages 2500-2504.
Crossref
Crossref
Dennis A. SmithKevin Beaumont, Tristan S. Maurer & Li Di. (2018) Clearance in Drug Design. Journal of Medicinal Chemistry 62:5, pages 2245-2255.
Crossref
Crossref
Yongjun Hu & David E. Smith. (2019)
In Silico Prediction of the Absorption and Disposition of Cefadroxil in Humans using an Intestinal Permeability Method Scaled from Humanized
PepT1
Mice
. Drug Metabolism and Disposition 47:3, pages 173-183.
Crossref
Crossref
Jie Shen, Brandon Swift, Richard Mamelok, Samuel Pine, John Sinclair & Mayssa Attar. (2018) Design and Conduct Considerations for First‐in‐Human Trials. Clinical and Translational Science 12:1, pages 6-19.
Crossref
Crossref
Teerachat Saeheng, Kesara Na-Bangchang & Juntra Karbwang. (2018) Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review. European Journal of Clinical Pharmacology 74:11, pages 1365-1376.
Crossref
Crossref
C.M. Bowman & L.Z. Benet. (2018) An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation. European Journal of Pharmaceutical Sciences 123, pages 502-514.
Crossref
Crossref
Sean D. Allen, Yu-Gang Liu, Sharan Bobbala, Lei Cai, Peter I. Hecker, Ryan Temel & Evan A. Scott. (2018) Polymersomes scalably fabricated via flash nanoprecipitation are non-toxic in non-human primates and associate with leukocytes in the spleen and kidney following intravenous administration. Nano Research 11:10, pages 5689-5703.
Crossref
Crossref
Weize Huang & Nina Isoherranen. (2018) Development of a Dynamic Physiologically Based Mechanistic Kidney Model to Predict Renal Clearance. CPT: Pharmacometrics & Systems Pharmacology 7:9, pages 593-602.
Crossref
Crossref
Zhe Li, Ben-Fillippo Krippendorff & Dhaval K. Shah. (2017) Influence of Molecular size on the clearance of antibody fragments. Pharmaceutical Research 34:10, pages 2131-2141.
Crossref
Crossref
Marion Bouillon-Pichault, Claire Brillac, Céline Amara, Céline Nicolazzi, Nathalie Fagniez, Jean-Baptiste Fau, Kimiko Koiwai, Samira Ziti-Ljajic & Christine Veyrat-Follet. (2017) Translational Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody-Drug Conjugates. The Journal of Clinical Pharmacology 57:7, pages 865-875.
Crossref
Crossref
Daniel Scotcher, Christopher Jones, Amin Rostami-Hodjegan & Aleksandra Galetin. (2016) Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance. European Journal of Pharmaceutical Sciences 94, pages 59-71.
Crossref
Crossref
M Sundqvist, A Lundahl, MB Någård, U Bredberg & P Gennemark. (2015) Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction. CPT: Pharmacometrics & Systems Pharmacology 4:4, pages 243-254.
Crossref
Crossref
C. D. Lee & L. K. Maxwell. (2014) Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses. Journal of Veterinary Pharmacology and Therapeutics 37:1, pages 35-42.
Crossref
Crossref
Hiroyuki Sayama, Hiroshi Komura & Motohiro Kogayu. (2013) Application of Hybrid Approach Based on Empirical and Physiological Concept for Predicting Pharmacokinetics in Humans—Usefulness of Exponent on Prospective Evaluation of Predictability. Drug Metabolism and Disposition 41:2, pages 498-507.
Crossref
Crossref
Miroslav Dostalek, Iain Gardner, Brian M. Gurbaxani, Rachel H. Rose & Manoranjenni Chetty. (2013) Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies. Clinical Pharmacokinetics 52:2, pages 83-124.
Crossref
Crossref
Alexander V. LyubimovMeihua Rose Feng, Nan Zheng, Xinyuan Zhang, Yea Min Huh & Jing‐yu Yu. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
36
.